A summary of the status of de novo cancer in transplant recipients.
D000293:Adolescent; D000328:Adult; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D005260:Female; D016027:Heart Transplantation; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation; D008223:Lymphoma / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000453:epidemiology* / Q000209:etiology; D009372:Neoplasms, Connective Tissue / Q000453:epidemiology; D009375:Neoplasms, Glandular and Epithelial / Q000453:epidemiology; D009380:Neoplasms, Nerve Tissue / Q000453:epidemiology; D011379:Prognosis; D011878:Radiotherapy; D013156:Splenectomy; D013934:Thymectomy; D013950:Thymus Gland / Q000528:radiation effects; D014019:Tissue Donors; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents